The interaction of pathogens with host tissues is a key step towards successful colonization and establishment of an infection. During bacteremia, pathogens can virtually reach all organs in the human body (e.g., heart, kidney, spleen) but host immunity, blood flow and tissue integrity generally prevents bacterial colonization. Yet, patients with cardiac conditions (e.g., congenital heart disease, atherosclerosis, calcific aortic stenosis, prosthetic valve recipients) are at a higher risk of bacterial infection. This protocol was adapted from an established ex vivo porcine heart adhesion model and takes advantage of the availability of heart tissues obtained from patients that underwent aortic valve replacement surgery. In this protocol, fresh tissues are used to assess the direct interaction of bacterial pathogens associated with cardiovascular infections, such as the oral bacterium Streptococcus mutans, with human aortic valve tissues.
28. Fixative solution (see Recipes) www.bio-protocol.org/e2316 Vol 7,  b. Immediately after surgery, tissues should be placed in a sterile specimen container, kept on ice and immediately taken to the laboratory for processing.
Tissue preparation
a. In a biosafety cabinet, open the vial containing the heart tissue and assess the level of calcification, inflammation and damage prior to further processing. Ideally, valve sections should be obtained from smooth areas with no calcification, signs of inflammation or residual blood ( Figure 1 ). b. With a biopsy punch, press firmly on the selected areas of the tissue to cut through and remove the section from the rest of the tissues (Figure 1 d. The number of sections that can be effectively obtained depends on the quality and the size of the tissue as well as on the type of experiment to be performed (see below). e. Incubate the 12-well plate containing the valve sections at 37 °C in a 5% CO2 atmosphere overnight (18-20 h).
Bacterial attachment to aortic valve tissues
a. On the same day of valve tissue processing, grow overnight bacterial cultures in triplicate.
To grow S. mutans OMZ175, add 2 ml of BHI in a 4 ml sterile culture tube and inoculate by picking a single isolated colony from a freshly streaked plate. b. Incubate cultures at 37 °C in a 5% CO2 atmosphere overnight (18-20 h) without aeration. c. On the following day, wash the valve sections twice at room temperature with HBSS buffer to remove residual antibiotics. For this, add 1 ml of HBSS into two clean empty wells of the same plate and transfer the sections using sterile tweezers. Gently rock plate containing valve sections for 5 min and set the rocker to a setting of 40-50 motions per minute for each wash step. d. In the meantime, centrifuge the overnight cultures at 3,500 x g for 10 min at 4 °C, wash twice with sterile PBS and resuspend cultures with the initial culture volume. e. For each strain replicate, add 2.7 ml of fresh EGM without antibiotics to a clean 4 ml sterile culture tube and 300 µl of the bacterial culture making a 1:10 dilution of the bacterial suspension (approximately 1 x 10 7 CFU ml -1 ).
f. Transfer washed valve sections to a new 12-well plate and add 1 ml of the bacterial suspension in EGM. In addition, take 100 µl of each replicate for serial dilution and plating of the initial culture CFU (T0). g. Incubate plate at 37 °C in a 5% CO2 atmosphere with gentle rocking for 90 min. In addition, take 100 µl of each mixed bacterial replicate for serial dilution and plating of the initial culture CFU (T0).
i. Incubate the inoculated valve sections at 37 °C in a 5% CO2 atmosphere with gentle rocking for 90 min. j. After incubation, transfer each valve section into a 1.7 ml microcentrifuge tube containing 1 ml of HBSS and then vortex at medium intensity for 5 sec. This process should be repeated three times in order to remove loosely bound bacteria. k. After washing, place each valve section in a 4 ml sterile culture tube containing 500 µl of PBS and homogenize the tissue for 2 min with a motorized pestle to detach tightly adhered bacteria.
l. Take 100 µl aliquot from the homogenized valve suspension for serial dilution and plating of the final culture on both BHI + Erm 10 µg ml -1 and BHI + Kan 1 mg ml -1 plates to determine the CFU (TF). m. Incubate inoculated plates at 37 °C in a 5% CO2 atmosphere. After 48 h, count colonies for CFU determination.
Data analysis
1. For visualization of bacterial adherence, tissues should be thoroughly examined by SEM ( Figure   2 ). The top and bottom parts of the tissues, which are the areas of the heart valve continuously exposed to arterial flow and are generally undamaged, are referred to as smooth surfaces. The edge of tissues, which are displaying collagen fibers due to rupture by the biopsy punch, is referred to as rough surfaces.
www.bio-protocol.org/e2316 3. Values are then plotted on a column scatter plot and analyzed using one-way ANOVA with
Bonferroni post hoc comparisons to determine substrate preferences among strain pairs. A CI value of 1 represents no difference in adherence between strains; a CI value lower than 1 represents less binding by test strain compared to the reference strain; a CI value higher than 1 represents more binding by the test strain compared to the reference strain.
A representative graph showing the competitive index (CI) of S. mutans OMZ175 and its ∆cnm counterpart is shown below. Each point in the graph represents an individual experiment using different tissue samples. The variability comes from the nature of the tissues since specimens are not exactly the same for every patient (Figure 3 ). Figure 3 . CI analysis of S. mutans OMZ175 and its ∆cnm counterpart. The CI values were calculated from CFU at T0 and TF for both strains using the CI formula described above. The mean CI was higher than 1 indicating that S. mutans OMZ175 outcompetes its ∆cnm counterpart. Expression of Cnm in OMZ175 enhances the bacterial capacity to adhere human aortic valve tissues.
Notes

All protocols involving human subject must be previously approved by an Institutional Review
Board. This protocol was established using discarded tissues from patients undergoing cardiac surgery for aortic valve replacement due to calcific stenosis. Patients younger than 18 years old, pregnant women and HIV-positive patients were excluded from the original study.
2. All tissues should be individually and thoroughly evaluated prior to the ex vivo binding analysis. This is due to the different levels of calcification, inflammation and tissue damage in each patient.
3. Tissues should be processed within 6 h of obtaining them. If required, tissues may be processed and placed in EGM + gentamicin 300 µg ml -1 for up to 72 h before performing colonization assay.
For this study, tissue visualization by SEM was performed by the University of Rochester
Medical Center Electron Microscopy Core. Samples were analyzed using a Zeiss-Auriga focused ion beam field emission scanning electron microscope (FIB-FE-SEM) and the images were captured using the attached Gatan Erlangshen digital camera.
5. The number of input bacteria (total number of bacterial cells added to the tissues) for the competition experiment was previously determined to be approximately similar for S. mutans OMZ175 and its ∆cnm counterpart. Similarly, CFU input should be determined for any bacterial strains to be tested prior to competition analysis. To maintain reproducibility, we suggest adjusting bacterial cultures to specific OD600 nm to match the number of CFUs between strains. 
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